| Literature DB >> 26644583 |
Kelsey L Tinkum1, Kristina M Stemler2, Lynn S White1, Andrew J Loza3, Sabrina Jeter-Jones2, Basia M Michalski4, Catherine Kuzmicki4, Robert Pless5, Thaddeus S Stappenbeck6, David Piwnica-Worms7, Helen Piwnica-Worms8.
Abstract
Short-term fasting protects mice from lethal doses of chemotherapy through undetermined mechanisms. Herein, we demonstrate that fasting preserves small intestinal (SI) architecture by maintaining SI stem cell viability and SI barrier function following exposure to high-dose etoposide. Nearly all SI stem cells were lost in fed mice, whereas fasting promoted sufficient SI stem cell survival to preserve SI integrity after etoposide treatment. Lineage tracing demonstrated that multiple SI stem cell populations, marked by Lgr5, Bmi1, or HopX expression, contributed to fasting-induced survival. DNA repair and DNA damage response genes were elevated in SI stem/progenitor cells of fasted etoposide-treated mice, which importantly correlated with faster resolution of DNA double-strand breaks and less apoptosis. Thus, fasting preserved SI stem cell viability as well as SI architecture and barrier function suggesting that fasting may reduce host toxicity in patients undergoing dose intensive chemotherapy.Entities:
Keywords: DNA damage; chemotherapy; fasting; stem cells
Mesh:
Substances:
Year: 2015 PMID: 26644583 PMCID: PMC4697381 DOI: 10.1073/pnas.1509249112
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205